Home Biosimilar Antibodies Neuronal Signaling MAO Simtuzumab (Anti-LOXL2)
For research use only. Not for use in humans.

Simtuzumab (Anti-LOXL2)

Synonyms: AB 0024, GS 6624

Simtuzumab (Anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2) with potential antineoplastic activity. MW: 145.5 kD.

Simtuzumab (Anti-LOXL2)

Quality Control

Batch: A240801 Purity: 99% Protein concentration: 11.22mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation MAO-A MAO-B MAO Others
Moclobemide (Ro 111163) 4
Vafidemstat 0 LSD1/KDM1A
Norharmane 1
MAO-B-IN-2 0 BChE
Xanthoangelol 1 dopamine-beta-hydroxylase
4-Hydroxyderricin 0
Toloxatone (MD69276) 0
TB5 0
Lazabemide 0
Harmine 5 PPARγ
Isatin 2
Sennoside A 2
Paeonol 2
Glycyrrhizin (Glycyrrhizic Acid, NSC 167409) 44 HMGB1,11 beta-hydroxysteroid dehydrogenase
Harmane 0
Iproniazid phosphate 0
Myristicin 0 CYP1A2
Hypericin 1 P450,Telomerase,Reverse transcriptase
Eprobemide 0
Iproniazid 0
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Simtuzumab (Anti-LOXL2) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2) with potential antineoplastic activity. MW: 145.5 kD.

Product Details

CAS No. 1318075-13-6
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.